Erschienen: 17.08.2017 Abbildung von Yarden / Elkabets | Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways | 2018

Yarden / Elkabets

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

2018. Buch. Book. Hardcover

Springer-Verlag GmbH. ISBN 978-3-319-67930-3

Format (B x L): 16.1 x 24.4 cm

Gewicht: 558 g

In englischer Sprache

Produktbeschreibung

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.

Autoren

  • Dieses Set enthält folgende Produkte:
      Auch in folgendem Set erhältlich:
      • nach oben

        Ihre Daten werden geladen ...